NCT06938906Active, not recruiting
Multimodal Therapy Impact on Pancreatic Cancer Survival
Survival Outcome Analysis on the Strategy Shift Integrating a Multimodal Therapy of Neoadjuvant Chemotherapy and Extended Pancreatectomy in Pancreatic Cancer: A Clinical Study From a Retrospective Cohort in a Single Institute
Source: ClinicalTrials.gov · Last updated 24 Apr 2025
Brief summary (registry, in English)
The goal of this retrospective cohort study is to analyze change of treatment strategies affect the survival outcomes in patients of pancreatic cancer who received curative-intent treatment. The main question it aims to answer is: Hypothesis: Change of treatment strategies involving increased utility of neoadjuvant chemotherapy and aggressive surgical approaches of extended pancreatectomy improved the overall and progression free survival in the patients with pancreatic cancer. Participants received curative treatment for pancreatic cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 405 (actual)
- First submitted
- 14 Apr 2025
- Start date
- 3 Jan 2011
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- National Cheng Kung University
- Diseases
- Pancreatic cancer
- NCT number
- NCT06938906
What you commit to
- Study type: Observational
- Participants enrolled: 405
- From 3 Jan 2011 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Cases with palliative or R2 resection were also excluded from the analysis.
Other illness
- Other subtypes of pancreatic cancer including acinar cell carcinoma, mucinous carcinoma, undifferentiated carcinoma and intraductal papillary mucinous neoplasm with associated adenocarcinoma
Who the study is looking for
- Pancreatic adenocarcinoma
- Received curative surgery
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cheng Kung University Hospital Coordinator of this site? Confirm its status | Tainan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.